a guide to shiresupport updated: spring 2012

14
Our purpose We enable people with life-altering conditions to lead better lives. A Guide to www.ShireSupport.com Updated: Spring 2012 Shire Pharmaceuticals-SP

Upload: ahanu

Post on 05-Jan-2016

45 views

Category:

Documents


6 download

DESCRIPTION

A Guide to www.ShireSupport.com Updated: Spring 2012. Shire Pharmaceuticals-SP. www.ShireSupport.com. The following slides provide an orientation on Shire Pharmaceuticals-SP Registration eligibility and submission Therapeutic areas Funding types Definitions of funding types - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: A Guide to ShireSupport Updated: Spring 2012

Our purpose

We enable people with life-altering conditions to lead better lives.

A Guide towww.ShireSupport.comUpdated: Spring 2012

Shire Pharmaceuticals-SP

Page 2: A Guide to ShireSupport Updated: Spring 2012

To be as brave as the people we help.

2

www.ShireSupport.com

• The following slides provide an orientation on• Shire Pharmaceuticals-SP• Registration eligibility and submission• Therapeutic areas• Funding types• Definitions of funding types• Funding availability• Contact information

Page 3: A Guide to ShireSupport Updated: Spring 2012

To be as brave as the people we help.

3

Registration and Submission Process

• Step One• Become a registered user of www.ShireSupport.com• When registering please have the following materials available

• Legal name of the organization as registered with the IRS• A signed PDF copy of the organization’s W9 form

• Note: Electronic signatures are NOT acceptable

• If applicable, a PDF copy of the organization’s non-profit determination letter from the IRS

• Step Two• Select the request type

• Medical education grants• Healthcare related Charitable Contributions and/or Sponsorship

requests

• Step Three• Submit the request with attachments as applicable

Page 4: A Guide to ShireSupport Updated: Spring 2012

To be as brave as the people we help.

4

Registration Eligibility

• Eligible• Medical Schools

• Hospitals/Medical Centers

• Medical Associations/Medical Societies

• Patient Advocacy Organizations

• Medical Education Companies

• Not for Profit organizations• 501(c)(3)(4)(6)

• Ineligible• Individuals

• Private or group medical practice(s)

• An organization that has been debarred or is on the OIG exclusion list

Notice to all requestors located in Massachusetts: due to the Massachusetts Pharmaceutical and Device Manufacturer Conduct Law, Shire is unable to fund requests for the financial support for the costs of travel, lodging, or other personal expenses of non-faculty health care practitioners attending any CME event, third-party scientific or educational conference, or professional meetings, either directly to the individuals participating in the event or indirectly to the event’s sponsor.  While Shire has information on the charitable section of this website relating to Fellows and Residents travel grants, any organizations located in Massachusetts are not eligible due to this law.

Page 5: A Guide to ShireSupport Updated: Spring 2012

To be as brave as the people we help.

5

Therapeutic Areas of Interest

• ADHD• Adult

• ADHD is a chronic neurologically based disease. Therefore Shire’s educational goal is to fund education that provides specialists with the information and tools needed to improve the screening, diagnosis, treatment, and management of adult patients with ADHD.

• Adolescents• ADHD is a chronic neurologically based disease. Therefore Shire’s

educational goal is to fund education that provides specialists with the information and tools needed to improve the screening, diagnosis, treatment, and management of adolescent patients with ADHD.

• Pediatric• ADHD is a chronic neurologically based disease. Therefore Shire’s

educational goal is to improve the screening, diagnosis, treatment, and management of pediatric patients with ADHD.

Page 6: A Guide to ShireSupport Updated: Spring 2012

To be as brave as the people we help.

6

Therapeutic Areas of Interest

• Gastroenterology • Mild to Moderate Ulcerative Colitis

• Mild to moderate ulcerative colitis is a disease characterized by inflammation and ulceration of the lining of the colon and rectum. Shire’s educational goal is to fund education that provides specialists with the information and tools needed to improve the screening, diagnosis, treatment, and management of patients with mild to moderate ulcerative colitis.

• Motility/Chronic Constipation• Chronic constipation is characterized by infrequent and difficult passage of

stools over a prolonged period and a range of bothersome symptoms. Shire’s educational goal is to fund education that provides specialists with the information and tools needed to improve the screening, diagnosis, treatment, and management of female patients with chronic constipation.

• Renal• Hyperphosphatemia

• Hyperphosphatemia is an abnormal concentration of phosphates in the blood. Shire’s educational goal is to fund education that provides specialists with the information and tools needed to improve the screening, diagnosis, treatment, and management of patients with hyperphosphatemia.

Page 7: A Guide to ShireSupport Updated: Spring 2012

To be as brave as the people we help.

7

Definitions of Funding Types

Funding Request Type Definition Therapeutic Areas

Independent Medical Education Grant

Examples include:

General meeting support for healthcare practitioner conference

Annual conference at medical school or association meeting

Session at annual meeting of local medical society

Consists of educational activities, which serve to maintain, develop, or increase the knowledge, skills, and professional performance, and relationships that a physician uses to provide services for patients, the public, or the profession.

Educational grants may be payable to organizations including hospitals, medical societies, medical schools, 501(c)(3)(4)(6) organizations, medical education companies, etc.

Funds are to educate broad audiences; cannot be used to fund education for sole individual.

Requesting organization has full control over selection of faculty, content, educational method, materials, venue etc.

Shire has no role in the development or implementation of the activity.

Shire Pharmaceuticals-SP• Gastroenterology – Mild to

Moderate Ulcerative Colitis• Gastroenterology – Motility/Chronic

Constipation• Hyperphosphatemia (Renal)• Pediatric Attention Deficit Hyperactivity

Disorder• Adolescent and Adult Attention Deficit

Hyperactivity Disorder

www.ShireSupport.com

Page 8: A Guide to ShireSupport Updated: Spring 2012

To be as brave as the people we help.

8

Definitions of Funding Types

Funding Request Type Definition Therapeutic Areas

Charitable Contributions

Examples include:

Fundraising events

General support of patient advocacy organizations

Donations to support the general activities of a registered tax-exempt organization under sections 501(c)(3)(4)(6) of the Internal Revenue Code, which are engaged in healthcare-related charitable purposes

All charitable giving must serve a clearly defined legitimate charitable purpose, and Shire may only receive an incidental benefit from any such contributions

Charitable contributions may be payable to organizations including hospitals, medical societies, medical schools, 501(c)(3)(4)(6) organizations, etc.

Use of charitable contribution funds is unrestricted, which means Shire does not control the recipient’s use of the funds; use is at the sole discretion of the recipient

Shire Pharmaceuticals-SP• Gastroenterology specific to mild to

moderate ulcerative colitis•Gastroenterology – Motility/Chronic

Constipation•Hyperphosphatemia (Renal)• Pediatric attention deficit hyperactivity

disorder• Adult attention deficit hyperactivity disorder

www.ShireSupport.com

Notice to all requestors located in Massachusetts: due to the Massachusetts Pharmaceutical and Device Manufacturer Conduct Law, Shire is unable to fund requests for the financial support for the costs of travel, lodging, or other personal expenses of non-faculty health care practitioners attending any CME event, third-party scientific or educational conference, or professional meetings, either directly to the individuals participating in the event or indirectly to the event’s sponsor.  While Shire has information on the charitable section of this website relating to Fellows and Residents travel grants, any organizations located in Massachusetts are not eligible due to this law.

Page 9: A Guide to ShireSupport Updated: Spring 2012

To be as brave as the people we help.

9

Definitions of Funding Types

Funding Request Type Definition Therapeutic Areas

Sponsorship Requests

Examples include:

Payments to become a tier (e.g., gold, platinum, etc.) sponsor at a medical society’s or patient advocacy group’s annual meeting

Payment for exhibit space at a medical conference or seminar

Patient Education

Support for healthcare-related events or activities where Shire may receive a material commercial benefit in exchange for its contribution

Sponsorships may be payable to organizations including hospitals, medical societies, medical schools, 501(c)(3)(4)(6) organizations, etc.

Shire does not fund sponsorships payable to individual healthcare providers or medical practices.

Shire Pharmaceuticals-SP• Gastroenterology specific to mild to

moderate ulcerative colitis•Gastroenterology – Motility/Chronic

Constipation•Hyperphosphatemia (Renal)• Pediatric attention deficit hyperactivity

disorder• Adult attention deficit hyperactivity disorder

www.ShireSupport.com

Page 10: A Guide to ShireSupport Updated: Spring 2012

To be as brave as the people we help.

10

Shire Pharmaceuticals-SP – 2012 Funding Availability

Therapeutic Area Educational Grants Healthcare Related Charitable Contributions and/or Sponsorship Requests

Adolescent and Adult Attention Deficit Hyperactivity Disorder

Limited Available

Gastroenterology – Mild to Moderate Ulcerative Colitis

Available Available

Gastroenterology – Motility/Chronic Constipation

Available Available

Hyperphosphatemia (Renal) Limited Limited

Pediatric Attention Deficit Hyperactivity Disorder

Limited Available

Page 11: A Guide to ShireSupport Updated: Spring 2012

To be as brave as the people we help.

11

Financial Reconciliation of Educational Grants

• Educational grants must be reconciled within 90 days of the activity date• Reconciliations are to be completed online at www.ShireSupport.com• What’s needed

• Complete the online reconciliation form with• Attendance information• Comparative budget to actual reconciliation (Program expenses for the

entire initiative; not just what Shire provided)• Total Funding received from all sources = registration income, educational

grants, and funding provided by the hosting organization• The evaluation summary• Documentation of the commercial support acknowledgement statement, i.e.

“This activity was supported by an independent medical educational grant from Shire.”

• Refunds are only due if the amount is greater than $250• Failure to reconcile educational grants may prevent future funding to

your organization.

Page 12: A Guide to ShireSupport Updated: Spring 2012

To be as brave as the people we help.

12

Financial Reconciliation of Sponsorships

• All sponsorships must be reconciled within 90 days of the activity date

• Reconciliations are to be completed online at www.ShireSupport.com

• What’s needed• Comparative budget to actual reconciliation

• Program expenses for the entire initiative must be included (not just funding provided by Shire)

• Documentation of the commercial support acknowledgement statement

• Note that failure to reconcile this request may prevent future Charitable and/or Sponsorship funding to your organization.

Page 13: A Guide to ShireSupport Updated: Spring 2012

To be as brave as the people we help.

13

Some Reminders…

• Funding requests must be aligned to a Shire Pharmaceuticals-SP therapeutic area of interest to be considered

• Funding requests must be submitted online to www.ShireSupport.com by the requesting organization without assistance from Shire employees

• Faxed, mailed, or e-mailed requests will not be reviewed

• Funding requests must be in compliance with all applicable guidelines• Timelines

• All requests – educational, charitable contributions, or sponsorships – must be submitted 60 days in advance

• Decisions are communicated by e-mail within 30-60 days of the request date

• Requests will not be reviewed or approved after the activity has begun or taken place• Submission, or past approvals, does not guarantee support• Declined requests cannot be resubmitted• Educational grant requests should not include sponsorship requests and vice versa • Questions?

• Shire Pharmaceuticals-SP: [email protected]

Page 14: A Guide to ShireSupport Updated: Spring 2012

To be as brave as the people we help.

14

Contact Information

Shire Pharmaceuticals-SP Shire HGTE-mail: [email protected] E-mail: [email protected]

Phone: 484-595-8253 Phone: 617-613-4999

Funding Site: www.ShireSupport.com Funding Site: www.ShireHGTsupport.com

Mail: Shire Pharmaceuticals-SP

725 Chesterbrook Blvd

Wayne, PA 19087

Mail: Shire HGT

300 Shire Way

Lexington, MA 02421

Therapeutic Areas of Interest

Adolescent and Adult Attention Deficit Hyperactivity Disorder

Gastroenterology – Mild to Moderate Ulcerative Colitis

Gastroenterology – Motility/Chronic Constipation

Hyperphosphatemia (Renal)

Pediatric Attention Deficit Hyperactivity Disorder

Therapeutic Areas

Fabry Diseas

Gaucher Disease

Hereditary Angioedema (HAE)

Hunter Syndrome

Metachromatic Leukodystrophy (MLD)

Sanfilippo Syndrome